Argent Biopharma operates a network of advanced facilities across Europe, each focused on driving innovation and ensuring patient access to high-quality, life-changing therapies.
Our Emonska R&D hub in Slovenia is staffed with over 40 highly experienced pharmaceutical professionals, all dedicated to developing advanced drug formulations and delivery systems. This site forms the backbone of our in-house research and innovation efforts, where our team drives the development of new therapies that meet unmet medical needs.
Key Features:
Advanced drug formulation and delivery system development
Continuous innovation and progress in drug development
Focus on early patient access and regulatory approval pathways
Certificate of GDP compliance of a distributor of active substances for use as starting materials (no. 455-26/2024-1), issued by JAZMP on 11.07.2024
Certificate of registration in the register of importers of active substances (no. 806-7/2024-5), issued by JAZMP on 11.07.2024
Certificate of registration in the register of wholesalers of active substances (no. 805-12/2024-5), issued by JAZMP on 11.07.2024
Certificate of registration in the register of brokers selling medicinal products and active substances (no. 807-1/2024-3), issued by JAZMP on 27.06.2024
Authorisation for the possession of illicit drugs (cannabinoids) (no. 187-31/2025/3), issued by Ministry of Health on 03.07.2025
